If you are wondering whether GSK is still good value after its strong run, you are not alone. This article will walk through ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying ...

GlaxoSmithKline (GSK) announced the purchase of 250,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 1,780.00p to 1,820.00p, ...

GSK (LSE:GSK) has quietly kept shareholders happy this year, with the stock climbing about 34% year to date and roughly 42% ...

FDA approves GSK's Exdensur for severe eosinophilic asthma, backed by Phase 3 data showing up to 58% fewer asthma attacks ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

We recently published 13 Best ADR Stocks to Invest In . GSK plc (NYSE:GSK) is one of the best ADR stocks.

Riad Mishlawi is stepping down from the top role by ‘mutual agreement’ with the firm’s board of directors, it told investors.

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

U.S. Medicare price cuts of up to 85% will have a lesser impact on drugmakers than initially feared, with most of the hit already reflected in forecasts, Wall Street analysts said.

Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), says the company is prioritising the United States for product launches and investment, ...